Evidence map›Paper›PMID 35369865›Full record

ArticleBMC nephrology2022

Correlation between intestinal flora disruption and protein-energy wasting in patients with end-stage renal disease.

Jianguang Hu, Xiaoshi Zhong, Yan Liu, Jing Yan, Daoyuan Zhou, Danping Qin, Xiao Xiao, Yuanyuan Zheng, Luona Wen, Rongshao Tan and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Frontiers in veterinary science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jianguang HuDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Xiaoshi ZhongDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China. 2453075701@qq.com.
Yan LiuDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China. rabbityan127@163.com.
Jing YanDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Daoyuan ZhouDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Danping QinDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Xiao XiaoDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Yuanyuan ZhengDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Luona WenDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Rongshao TanDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Pan LiangDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Yun LiuDepartment of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, 510220, China.
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDifferent dialysis treatments may affect the composition and structure of the intestinal flora of dialysis-treated chronic kidney disease (CKD) patients. This study aimed to analyze the correlations between the different flora and the nutritional indexes and further explore the potential metabolic pathways in patients with CKD in end-stage renal disease (ESRD).

methodsAltogether, 102 patients with ESRD were recruited and categorized into the hemodialysis (HD) group (N = 49) and the peritoneal dialysis (PD) group (N = 53). Their biochemical indexes, anthropometric indicators, and inflammatory markers were determined. The total genomic DNA was extracted for 16S ribosomal DNA sequencing. Furthermore, bioinformatics analysis was employed for functional analysis.

resultsAnthropometric indicators, including handgrip strength, mid-upper arm circumference, mid-upper arm muscle circumference, and body mass index, in the HD and PD groups showed a positive correlation with butyric acid-producing bacteria (Rosella and Phascolarctobacterium) and a negative correlation with conditional pathogens (Escherichia spp.). Meanwhile, the inflammatory markers, including high-sensitivity C-reactive protein and interleukin-6, were significantly higher in the PD-protein-energy wasting (PEW) group than in the PD-non-protein-energy wasting (NPEW) group; although they showed an increasing trend in the HD-PEW group, no significant difference was noted. Rosella was considerably scarce in the HD-PEW group than in the HD-NPEW group, whereas Escherichia was substantially more abundant in the PD-PEW group than in the PD-NPEW group. Compared with the HD group, the essential amino acid synthesis pathway, amino acid metabolism-related enzyme pathways, and aminoacyl-transfer RNA biosynthesis pathways were weakened in the PD group. Most carbohydrate metabolic pathways were weakened, although the tricarboxylic acid cycle was slightly enhanced. Concurrently, the fatty acid metabolism was enhanced, whereas fatty acid synthesis was weakened; the metabolic pathways of B vitamins were also weakened. These potential metabolic pathways of the various compounds released by intestinal flora showed a significant correlation with blood biochemical indexes, anthropometric indicators, and inflammatory markers.

conclusionIn patients with ESRD, different dialysis treatments affected the abundance of butyric acid-producing bacteria (Rosella and Phascolarctobacterium) and conditional pathogens (Escherichia spp.). Butyric acid-producing bacteria showed a positive correlation with PEW and showed a negative correlation with Escherichia. Improving the intestinal diversity and increasing the amount of butyric acid-producing bacteria, such as Blautella, Faecococcus, and Phascolarctobacterium, are potential therapeutic approaches to enhance protein-energy consumption in patients with ESRD.

Indexed as

Gastrointestinal MicrobiomeKidney Failure, ChronicHand StrengthHumansNutritional StatusRenal Dialysis16S ribosomal DNA sequencingEnd-stage renal diseaseHemodialysisIntestinal flora

Identifiers

PMID35369865
PMCPMC8978364
OpenAlexW4225612070

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.